Prophylaxis of Post-Inflammatory Hyperpigmentation From Energy-Based Device Treatments: A Review
| Autor: | Ian T Y Wong, Vincent Richer |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
business.industry Post-inflammatory hyperpigmentation Brimonidine Dermatology Disease medicine.disease Hyperpigmentation Iatrogenesis 030207 dermatology & venereal diseases 03 medical and health sciences 0302 clinical medicine 030220 oncology & carcinogenesis Energy based medicine Surgery medicine.symptom business Psychosocial Tranexamic acid medicine.drug |
| Zdroj: | Journal of Cutaneous Medicine and Surgery. 25:77-86 |
| ISSN: | 1615-7109 1203-4754 |
| DOI: | 10.1177/1203475420957633 |
| Popis: | Post-inflammatory hyperpigmentation (PIH) is an acquired hypermelanosis that can result from inflammatory dermatologic disease, trauma, or iatrogenesis from procedures. This condition disproportionately affects individuals with skin of color, and it can place a significant psychosocial burden on affected patients. The management of PIH is, therefore, of great interest to clinicians, especially dermatologists. The treatment of established PIH has long been a principal focus within the literature, with publications on the topic outnumbering publications on prophylaxis of PIH. Prophylaxis strategies to prevent PIH vary greatly in clinical practice, likely due to the absence of an evidence-based consensus. Published approaches to PIH prophylaxis include pretreatment (topical alpha hydroxy acids, retinoids, hydroquinone, and brimonidine) and post-treatment strategies (photoprotection, corticosteroids, and tranexamic acid). This review will examine the current literature on prophylaxis of PIH from energy-based device treatments. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|